zurück

Isoflurane (known active substance with new data exclusivity: sedation of mechanically ventilated patients during intensive care)

Subject:

  • Active Substance: Isoflurane
  • Name: Sedaconda®
  • Therapeutic area: Sedation of mechanically ventilated patients during intensive care
  • Pharmaceutical company: Sedana Medical AB

Time table:

  • Start: 01.02.2022
  • Final decision by G-BA: 21.07.2022

Final decision:

  • No additional benefit